Evidence map›Paper›PMID 29908304›Full record

ReviewToxicology in vitro : an international journal published in association with BIBRA2018

Pathway-based predictive approaches for non-animal assessment of acute inhalation toxicity.

Amy J Clippinger, David Allen, Holger Behrsing, Kelly A BéruBé, Michael B Bolger, Warren Casey, Michael DeLorme, Marianna Gaça, Sean C Gehen, Kyle Glover and 25 more

Abstract readReview
In one paragraph

Review in Toxicology in vitro : an international journal published in association with BIBRA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. New approach methodologies (NAMs) for theFrontiers in toxicology · 2024
    Review
  9. Human cell-based in vitro systems to assess respiratory toxicity: a case study using silanes.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Computational toxicology (Amsterdam, Netherlands) · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Amy J ClippingerPETA International Science Consortium Ltd., Society Building, 8 All Saints Street, London N1 9RL, United Kingdom. Electronic address: amyjc@piscltd.org.uk.
David AllenIntegrated Laboratory Systems, Contractor Supporting the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods, Research Triangle Park, NC, United States.
Holger BehrsingInstitute for In Vitro Sciences, 30 West Watkins Mill Road, Suite 100, Gaithersburg, MD 20878, United States.
Kelly A BéruBéCardiff School of Biosciences, Museum Avenue, CF10 3AX, Wales, United Kingdom.
Michael B BolgerSimulations Plus, Inc., 42505 10th Street West, Lancaster, CA 93534, United States.
Warren CaseyNIH/NIEHS/DNTP/NICEATM, Research Triangle Park, North Carolina 27709, United States.
Michael DeLorme3M, 220-6E-03, St. Paul, MN 55144, United States.
Marianna GaçaBritish American Tobacco plc, Globe House, 4 Temple Place, London WC2R 2PG, United Kingdom.
Sean C GehenDow AgroSciences, Indianapolis, IN, United States.
Kyle GloverDefense Threat Reduction Agency, Aberdeen Proving Ground, MD 21010, United States.
Patrick HaydenMatTek Corporation, 200 Homer Ave, Ashland, MA 01721, United States.
Paul HinderliterSyngenta, Greensboro, NC, United States.
Jon A HotchkissThe Dow Chemical Company, Midland, MI 48674, United States.
Anita IskandarPhilip Morris Products SA, Philip Morris International R&D, Neuchâtel, Switzerland.
Brian KeyserRAI Services Company, 401 North Main Street, Winston-Salem, NC 27101, United States.
Karsta LuettichPhilip Morris Products SA, Philip Morris International R&D, Neuchâtel, Switzerland.
Lan Ma-HockBASF SE, Carl-Bosch-Strasse 38, 67056 Ludwigshafen am Rhein, Germany.
Anna G MaioneMatTek Corporation, 200 Homer Ave, Ashland, MA 01721, United States.
Patrudu MakenaRAI Services Company, 401 North Main Street, Winston-Salem, NC 27101, United States.
Jodie MelbournePETA International Science Consortium Ltd., Society Building, 8 All Saints Street, London N1 9RL, United Kingdom.
Lawrence Milchak3M, 220-6E-03, St. Paul, MN 55144, United States.
Sheung P NgE.I. du Pont de Nemours and Company, DuPont Haskell Global Center for Health Sciences, P. O. Box 30, Newark, DE 19714, United States.
Alicia PainiEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Kathryn PageThe Clorox Company, 4900 Johnson Dr, Pleasanton, CA 94588, United States.
Grace PatlewiczU.S. Environmental Protection Agency, Office of Research and Development, National Center for Computational Toxicology, Research Triangle Park, NC, United States.
Pilar PrietoEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Hans RaabeInstitute for In Vitro Sciences, 30 West Watkins Mill Road, Suite 100, Gaithersburg, MD 20878, United States.
Emily N ReinkeU.S. Army Public Health Center, 8252 Blackhawk Rd. Bldg. E-5158, ATTN: MCHB-PH-HEF Gunpowder, MD 21010-5403, United States.
Clive RoperCharles River Edinburgh Ltd., Edinburgh EH33 2NE, United Kingdom.
Jane RoseProcter & Gamble Co, 11530 Reed Hartman Highway, Cincinnati, OH 45241, United States.
Monita SharmaPETA International Science Consortium Ltd., Society Building, 8 All Saints Street, London N1 9RL, United Kingdom.
Wayne SpooRAI Services Company, 401 North Main Street, Winston-Salem, NC 27101, United States.
Peter S ThorneUniversity of Iowa College of Public Health, Iowa City, IA, United States.
Daniel M WilsonThe Dow Chemical Company, Midland, MI 48674, United States.
Annie M JarabekU.S. Environmental Protection Agency, Office of Research and Development, National Center for Environmental Assessment, Research Triangle Park, NC, United States.

Funding

Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Amy Leanne Ryan · 1998 to 2026
$30.5M
Biomolecular Screening and Alternative Approaches for the National Toxicology ProgramZIAES103318 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CASEY, WARREN · 2016 to 2021
$25.0M
NIDDK NIH HHS P30 DK054759NIEHS NIH HHS HHSN273201500010C
6 · The paper itself

Abstract

New approaches are needed to assess the effects of inhaled substances on human health. These approaches will be based on mechanisms of toxicity, an understanding of dosimetry, and the use of in silico modeling and in vitro test methods. In order to accelerate wider implementation of such approaches, development of adverse outcome pathways (AOPs) can help identify and address gaps in our understanding of relevant parameters for model input and mechanisms, and optimize non-animal approaches that can be used to investigate key events of toxicity. This paper describes the AOPs and the toolbox of in vitro and in silico models that can be used to assess the key events leading to toxicity following inhalation exposure. Because the optimal testing strategy will vary depending on the substance of interest, here we present a decision tree approach to identify an appropriate non-animal integrated testing strategy that incorporates consideration of a substance's physicochemical properties, relevant mechanisms of toxicity, and available in silico models and in vitro test methods. This decision tree can facilitate standardization of the testing approaches. Case study examples are presented to provide a basis for proof-of-concept testing to illustrate the utility of non-animal approaches to inform hazard identification and risk assessment of humans exposed to inhaled substances.

Indexed as

Animal Testing AlternativesToxicity Tests, AcuteAdministration, InhalationDecision TreesHumansAcute inhalation toxicityAdverse outcome pathwayAggregate exposure pathwayDosimetryEx vivoIn silicoIntegrated approach to testing and assessment (IATA)In vitroQuantitative structure-activity relationships (QSAR)Risk assessment

Identifiers

PMID29908304
PMCPMC6760245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.